American Healthcare Reit is a healthcare facility REIT company located in California, United States, which is part of the Real Estate sector, and is traded under the ticker AHR on the NYSE exchange.
American Healthcare Reit stock last closed at $50.31, down 0.26% from the previous day, and has increased 74.08% in one year. It has overperformed other stocks in the REIT - Healthcare Facilities industry by 0.56 percentage points. American Healthcare Reit stock is currently +90.57% from its 52-week low of $26.40, and -1.18% from its 52-week high of $50.91.
As of Dec 3, 2025, there are 176.91M shares of AHR outstanding. The market capitalization of AHR is $8.90B. In the past 24 hours, 2.1M AHR shares were traded.
You will need a brokerage account in order to access the NYSE market and buy AHR stock.
We believe that eToro is the best online stock brokerage. Here's why:
Get $10 towards your purchase of shares by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountNow that you've selected the best brokerage, you need to fill out some personal details so you are able to buy AHR stock today.
Now that you have finished signing up on one of the best stock trading apps, you need to deposit funds:
Check out the video below if you need help transferring funds into your brokerage account.
After you have selected the best place to buy American Healthcare Reit stock, it's absolutely critical to evaluate their stock prior to investing, so you actually comprehend the risk as well as the upside.
WallStreetZen was built to help everyday investors perform more in-depth fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on AHR's stock page.
Investors use a variety of different financial metrics, analyses, models, and charts to gauge AHR's fair value.
Using relative valuations metrics:
You can do more valuation research on AHR's stock here.
Out of 9 sell side analysts who monitor AHR, the consensus analyst rating on AHR is a Strong Buy
Please keep in mind that analyst ratings are not recommendations, nor are they financial advice.
Austin Wurschmidt, a top 21% analyst from KeyBanc maintains AHR with a strong buy rating and raises their AHR price target from $43.00 to $55.00, on Nov 13, 2025.
KeyBanc's Austin Wurschmidt raised their price target on American Healthcare Reit (NYSE: AHR) by 27.9% from $43 to $55 on 2025/11/13. The analyst maintained their Strong Buy rating on the stock.
American Healthcare REIT reported its Q3 2025 earnings.
Wurschmidt predicted that the company's ISHC and SHOP divisions will have solid fundamentals in 2026.
Additionally, the analyst pointed out that the company's demand funnel shows less seasonality in the near future, and its portfolio is ready to take advantage of demographic tailwinds.
American Healthcare REIT's investment pipeline is showing signs of improvement, Wurschmidt added, noting that the company's balance sheet is in good shape and its cost of capital is becoming better.
For Q3 2025, American Healthcare Reit reported:
For FY 2025, management guided:
President & CEO Danny Prosky commented: "I'm pleased with our ability to continue executing across all areas of our business.
"Organic growth continues to exceed historical levels, and across our operating portfolio, comprised of our ISHC and SHOP segments, we have benefited from strong secular demand tailwinds in the long-term care sector, highlighted by spot Same-Store SHOP occupancy currently being above 90%.
“On the capital allocation front, we continue to see favorable transaction activity, which we anticipate will allow us to add to the over $575M of new acquisitions we've closed YTD in 2025."
Michael Carroll, a top 23% analyst from RBC Capital maintains AHR with a buy rating and raises their AHR price target from $45.00 to $54.00, on Nov 12, 2025.
Aaron Hecht, a top 28% analyst from Citizens maintains AHR with a buy rating and raises their AHR price target from $50.00 to $60.00, on Nov 10, 2025.
Wesley Golladay, a bottom 9% analyst from Baird initiates coverage on AHR with a buy rating and announces their AHR price target of $41.00, on Jul 18, 2025.
You can dig deeper into what analysts are saying on the American Healthcare Reit stock forecast page.
Last year, AHR revenue was $2.20B. Over the past three year, AHR's revenue has gone up by 74.48% per year. This was faster than the REIT - Healthcare Facilities industry average of 15.6%.
Find out more about AHR's earnings and revenue performance here.
Over the past year, insiders at AHR have sold more shares than they have bought.
Mark E. Foster, EVP GC Secretary of AHR, was the latest AHR insider to sell. They sold $74,029.50 worth of AHR stock on Nov 11, 2025.
Learn more about who owns AHR stock here.
American Healthcare Reit pays a dividend of 1.49%, compared to the REIT - Healthcare Facilities industry's average dividend yield of 5.06%. If you owned $1,000 worth of AHR stock, you would have been paid $14.91 in the past 12 months.
Find more data about American Healthcare Reit dividend yield and history here.
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other traders have to say.
You have two primary options:
Press the Open Trade button and your broker will place your order.
If you require additional help buying stocks on eToro, click the how to video below:
Now that you own some AHR stock, you'll want to stay up-to-date on your company.
Put AHR on a watchlist to keep tabs on your AHR stock.
To summarize, here are the 6 steps to buy American Healthcare Reit stock:
If you are looking for a place to buy stocks, eToro is our recommended venue.
Get Started with eToro TodayIf you want to track your new investment in American Healthcare Reit, create your watchlist below.